Market Cap (In GBp)
15 Million
Revenue (In GBp)
6.13 Million
Net Income (In GBp)
-1.27 Million
Avg. Volume
135.67 Thousand
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.5-13.0
- PE
- -
- EPS
- -
- Beta Value
- 0.211
- ISIN
- GB00BLF79J41
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Chris Henry Francis Yates
- Employee Count
- -
- Website
- https://www.abingdonhealth.com
- Ipo Date
- 2020-12-15
- Details
- Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
More Stocks
-
NATPLAS
-
ALPSINDUSAlps Industries Limited
ALPSINDUS
-
TOYOFToyota Motor Corporation
TOYOF
-
GFSTEELSGrand Foundry Limited
GFSTEELS
-
TIGITigi Ltd.
TIGI
-
BCHEYBeach Energy Limited
BCHEY
-
CEG
-
AJLGFAJ Lucas Group Limited
AJLGF